Independent Advisor Alliance Has $5.04 Million Stock Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Independent Advisor Alliance boosted its holdings in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 19.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 58,398 shares of the company’s stock after acquiring an additional 9,647 shares during the quarter. Independent Advisor Alliance owned 0.94% of VanEck Pharmaceutical ETF worth $5,039,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Stifel Financial Corp raised its stake in shares of VanEck Pharmaceutical ETF by 13.4% during the 3rd quarter. Stifel Financial Corp now owns 7,810 shares of the company’s stock worth $742,000 after purchasing an additional 924 shares in the last quarter. Jane Street Group LLC raised its stake in shares of VanEck Pharmaceutical ETF by 124.0% in the 3rd quarter. Jane Street Group LLC now owns 19,436 shares of the company’s stock valued at $1,847,000 after acquiring an additional 10,759 shares in the last quarter. FMR LLC raised its stake in shares of VanEck Pharmaceutical ETF by 12.5% in the 3rd quarter. FMR LLC now owns 1,905 shares of the company’s stock valued at $181,000 after acquiring an additional 212 shares in the last quarter. Townsquare Capital LLC raised its stake in shares of VanEck Pharmaceutical ETF by 3.8% in the 3rd quarter. Townsquare Capital LLC now owns 3,519 shares of the company’s stock valued at $334,000 after acquiring an additional 130 shares in the last quarter. Finally, Harbour Investments Inc. raised its stake in shares of VanEck Pharmaceutical ETF by 16.6% in the 3rd quarter. Harbour Investments Inc. now owns 3,425 shares of the company’s stock valued at $325,000 after acquiring an additional 488 shares in the last quarter.

VanEck Pharmaceutical ETF Stock Performance

Shares of PPH stock opened at $92.52 on Wednesday. The stock’s 50 day simple moving average is $89.27 and its 200 day simple moving average is $91.26. VanEck Pharmaceutical ETF has a twelve month low of $84.48 and a twelve month high of $99.51. The company has a market capitalization of $577.32 million, a price-to-earnings ratio of 30.55 and a beta of 0.72.

VanEck Pharmaceutical ETF Increases Dividend

The firm also recently announced a dividend, which was paid on Monday, December 30th. Shareholders of record on Friday, December 27th were issued a $0.411 dividend. The ex-dividend date of this dividend was Friday, December 27th. This is a positive change from VanEck Pharmaceutical ETF’s previous dividend of $0.36.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.